Active Knee Prosthesis Study for Improvement of Locomotion for Above Knee Amputees
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to develop a robust, low-power, stable, and light weight, active knee prosthetic device that can dramatically increase gait symmetry and walking economy of a transfemoral amputee during walking.
State of the art prosthetic knees can be classified into three main classes: a) mechanically passive, b) variable-damping, and c) powered. Although the devices within each of these classes offer some advantages for above-knee amputees, their overall performance still presents some deficiencies. Artificial knees in the first two groups are predominantly damping devices, incapable of providing positive power output. Moreover, current powered prostheses are heavy and inefficient in their energy consumption, and/or they have a limited range of motion. To overcome such inadequacies, we have designed a novel prosthetic knee device with a biomimetic approach.
The design of the active knee prosthesis is inspired by the antagonistic muscle anatomy of the human knee joint. This device mimics the synergistic muscle activity at the knee using a double series-elastic actuator (SEA) system that resembles the major mono-articular muscle groups that help flex and extend the knee joint. The agonist-antagonist SEA knee architecture will allow for precise force control of the knee joint, mimicking the spring-like behavior of the human knee, as well as providing adequate energy for forward progression of the body. The SEA has been previously developed and tested on legged robots. Also, the SEA has been successfully applied to the development of an actuated ankle-foot orthoses (AAFO) at MIT AI Lab.
The mechanical architecture of the active knee prosthesis allows for independent engagement of flexion and extension tendon-like, series springs for the control of joint position and impedance, as well as net joint torque. Furthermore, this architecture permits a joint rotation with near zero friction, allowing the controller to take advantage of the passive dynamics of the system, thus, augmenting the overall energetic efficiency of the system.
| Condition | Intervention |
|---|---|
|
Amputation |
Device: Active Knee Prosthesis |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | The Active Knee Prosthesis Will be Tested to Evaluate How Well it Improves the Gait Symmetry and Reduces the Metabolic Cost of an Amputee During Walking. The Prosthesis Will be Attached to the Socket of the Amputee. |
| Estimated Enrollment: | 10 |
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | April 2009 |
| Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Prosthesis
Motorized External Knee prosthesis for above knee amputees. Comprised of agonist and antagonist actuators to mimic behavior of knee joint during locomotion.
|
Device: Active Knee Prosthesis
Motorized External Knee Prosthesis for above knee amputees.
Other Name: Agonist Antagonist Knee Prosthesis
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- They will be experienced at prosthesis ambulation
- Capacity of ambulation at least at a K3 level (i.e. having the ability or potential for ambulation with variable cadence).
Exclusion Criteria:
- Amputee participants will be generally healthy and will have no other musculoskeletal problems or any known cardiovascular, pulmonary or neurological disorders.
Contacts and Locations| Contact: Hugh Herr, Ph,D | 617 258 6574 | hherr@media.mit.edu |
| Contact: Robert Emerson, CP | 978-688-7900 | emerson@lifestyle-po.com |
| United States, Massachusetts | |
| Biomechatronics Research Group, MIT | Recruiting |
| Cambridge, Massachusetts, United States, 02142 | |
| Contact: Hugh Herr, Ph.D. 617-258-6574 hherr@media.mit.edu | |
| Contact: Ernesto Martinez, S.M. 617 324 1316 ernesto@media.mit.edu | |
| Principal Investigator: Hugh Herr, Ph.D. | |
| Sub-Investigator: Ernesto Martinez, S.M. | |
| Sub-Investigator: Grant Elliott, M.Eng. | |
| LIfestyle Prosthetics & Orthotics | Recruiting |
| North Andover, Massachusetts, United States, 01845 | |
| Contact: Robert Emeson, CP 978-688-7900 emerson@lifestyle-po.com | |
| Principal Investigator: | Hugh Herr, Ph.D. | Massachusetts Institute of Technology |
More Information
No publications provided by Providence VA Medical Center
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Hugh Herr, Ph.D., Massachusetts Institute of Technology |
| ClinicalTrials.gov Identifier: | NCT00771589 History of Changes |
| Other Study ID Numbers: | 0804002682 |
| Study First Received: | October 8, 2008 |
| Last Updated: | October 10, 2008 |
| Health Authority: | United States: Federal Government |
ClinicalTrials.gov processed this record on May 16, 2013